Abstract:Background & Aims To identify metabolic signatures associated with exposure to ambient air pollution and to explore their associations with risk of metabolic dysfunction-associated steatotic liver disease (MASLD). Methods We utilized data from the UK Biobank Cohort. Annual mean concentrations of PM 2.5 , PM 10 , NO 2 and NO x were assessed for each participant using bilinear interpolation. The Elastic Net regression model was used to identify metabolites associated with four air pollutants and to construct metabolic signatures, respectively. Associations between air pollutants, metabolic signatures and MASLD were analyzed using Cox models. Mendelian randomization (MR) analysis was used to examine potential causality. Mediation analysis was employed to examine the role of metabolic signatures in the association between air pollutants and MASLD. Results A total of 244,842 participants from the UK Biobank were included in this analysis. We identified 87, 65, 76, and 71 metabolites as metabolic signatures of PM 2.5 , PM 10 , NO 2 , and NO x , respectively. Metabolic signatures were associated with risk of MASLD, with hazard ratios (HRs) and 95% confidence intervals (95% CIs) were 1.10 (1.06, 1.14), 1.06 (1.02, 1.10), 1.24 (1.20, 1.29) and 1.14 (1.10, 1.19). The four pollutants were associated with increased risk of MASLD, with HRs (95% CIs) of 1.03 (1.01, 1.05), 1.02 (1.01, 1.04), 1.01 (1.01, 1.02) and 1.01 (1.00, 1.01). MR analysis indicated an association between PM 2.5 , NO 2 and NO x -related metabolic signatures and MASLD. Metabolic signatures mediated the association of PM 2.5 , PM 10 , NO 2 and NO x with MASLD. Conclusion There may be association between PM 2.5 , PM 10 , NO 2 and NO x -related metabolic signatures and MASLD, and metabolic signatures mediate the increase of PM 2.5 , PM 10 , NO 2 and NO x in the risk of MASLD. Impact and implications Air pollution is a significant public health issue and an important risk factor for metabolic dysfunction-associated steatotic liver disease (MASLD), however, the mechanism by which air pollution affects MASLD remains unclear. Our study used integrated serological metabolic data of 251 metabolites from a large-scale cohort study to demonstrate that metabolic signatures play a crucial role in the elevated risk of MASLD caused by air pollution. These results are relevant to patients and policymakers because they suggest that air pollution-related metabolic signatures are not only potentially associated with MASLD but also involved in mediating the process by which PM 2.5 , PM 10 , NO 2 , and NO x increase the risk of MASLD. Focusing on changes in air pollution-related metabolic signatures may offer a new perspective for preventing air pollution-induced MASLD and serve as protective measures to address this emerging public health challenge.

Association between metabolic dysfunction-associated steatotic liver disease and pulmonary function: a population-based and two-sample mendelian randomization study

Immune Cells and Blood Lipids Mediation: a Mendelian Randomization Study on Metabolic Dysfunction-Associated Fatty Liver Disease

Effects of Homocysteine on Nonalcoholic Fatty Liver Related Disease: A Mendelian Randomization Study

Metabolic-dysfunction associated steatotic liver disease-related diseases, cognition and dementia: A two-sample mendelian randomization study

Serum folate levels and risk of metabolic dysfunction-associated steatotic liver disease: results from a cross-sectional study and Mendelian randomization analysis

Causal relationship between depression and metabolic dysfunction-associated steatotic liver disease: a bidirectional Mendelian randomized study

Causal relationship between air pollution, lung function, gastroesophageal reflux disease, and non-alcoholic fatty liver disease: univariate and multivariate Mendelian randomization study

Genetic liability to asthma and risk of cardiovascular diseases: A Mendelian randomization study

Association of metabolic signatures of air pollution with MASLD: Observational and Mendelian randomization study

Genetically predicted metabolites mediate the association between immune cells and metabolic dysfunction-associated steatotic liver disease: a mendelian randomization study

Genetic associations of birthweight, childhood, and adult BMI with metabolic dysfunction-associated steatotic liver disease: a Mendelian randomization

Non-linear association between long-term air pollution exposure and risk of metabolic dysfunction-associated steatotic liver disease

Exploring the Relationship Between Air Pollution, Non-Alcoholic Fatty Liver Disease, and Liver Function Indicators: a Two-Sample Mendelian Randomization Analysis Study

Genetically Determined Circulating Saturated and Unsaturated Fatty Acids and the Occurrence and Exacerbation of Chronic Obstructive Pulmonary Disease-A Two-Sample Mendelian Randomization Study

Associations of the EAT-Lancet Reference Diet with Metabolic Dysfunction-Associated Steatotic Liver Disease and Its Severity: a Multi-Cohort Study

Associations of the EAT-Lancet reference diet with metabolic dysfunction–associated steatotic liver disease and its severity: A multicohort study

Associations of Cannabis Use, Metabolic Dysfunction-Associated Steatotic Liver Disease, and Liver Fibrosis in U.S. Adults

Cardiometabolic Phenotype Linked to Fibrosis and Mortality in Metabolic Dysfunction-Associated Steatotic Liver Disease

Investigation of the Association between Air Pollution and Non-Alcoholic Fatty Liver Disease in the European Population: A Mendelian Randomization Study

Mendelian randomization study of childhood asthma and chronic obstructive pulmonary disease in European and East Asian population

Multisystem health comorbidity networks of metabolic dysfunction-associated steatotic liver disease